"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative Vaccines" BOSTON ...

Also on Trump’s mind is the Federal Reserve. Its chair Jay Powell will on Wednesday unveil the US central bank’s decision on interest rates. The uncomfortable relationship between the president and ...

GSK is expected to report profit of £4.4 billion for the first half of this year. AstraZeneca is forecast to report a ...

The Duke of Gloucester has visited the University of Oxford to tour two of its leading medical research centres. Prince Richard was shown around the Clinical BioManufacturing Facility and the ...

Tuesday (July 29): First anniversary of the Southport stabbings; Supreme Court judgments on Russia sanctions and taxi ...

A slew of countries will face steep levies, including a 50% tariff on imports from Brazil and a 30% tariff on the European ...

Chronic hepatitis B treatment relies on nucleoside or nucleotide analogue drugs that suppress hepatitis B virus (HBV) ...

The Global Metabolism Drugs Market, valued at approximately USD 16.10 billion in 2022, is projected to grow at a robust CAGR of more than 6.50% during the forecast period from 2023 to 2030. Metabolism ...

Visit BBC for trusted reporting on the latest world and US news, sports, business, climate, innovation, culture and much more.

According to Research by SNS Insider, The U.S. GLP-1 Receptor Agonist Market to Reach USD 113.13 Billion by 2032, Driven by Rising Prevalence of Type 2 Diabetes and Demand for Obesity-Related ...